This editorial explains who is responsible for monitoring surface contamination of hazardous drugs, and why it is so important

This short article summarises the main barriers to safe handling of hazardous drugs from the perspectives of nurses

This 2-page evaluation summarises key findings from a review of surface contamination monitoring in hospital pharmacy departments conducted by the Spanish Society of Hospital Pharmacists (SEFH).

A multidisciplinary panel of healthcare providers met at the 2020 Safe to Touch conference and developed a set of consensus statements regarding hazardous drug surface contamination monitoring. This infographic summarises their recommendations.

Surface contamination poses risks to healthcare workers and patients. In this month’s editorial, read about the importance of surface contamination monitoring to reduce hazardous drug exposure.

Dr Nicolas Simon introduces his updated module which delves into the problem of decontaminating antineoplastic drug compounding facilities.

Mark Santillo answers key questions on what constitutes acceptable hazardous drug risk assessment and highlights the most common failing. Watch the intro video or go direct to the module!